Genevoyager

Private

WuhanHealthcare & Life Scienceshttps://genevoyager.ltd/

Last Round

Series A

Sep 12, 2023

Total Funding Raised

$32.77M

Company Overview

Genevoyager is a biotechnology company that provides one-stop Contract Research, Development, and Manufacturing Organization (CRO/CDMO) services for gene therapy products, specializing in large-scale viral vector preparation and delivery technologies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

contract development and manufacturing organizationCDMOcontract research organizationCROadeno-associated virusAAVviral vector productiongene therapy manufacturingbaculovirus expression systembiotech outsourcingviral vector packagingcGMP manufacturingpreclinical researchstem cell servicesanimal disease models

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genevoyager Comps

Public and private peers based on sector, stage, and business model.

Genevoyager comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Genevoyager Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Sep 12, 2023
Series A	Aug 1, 2023
Pre Seed	Jun 1, 2022

View all Funding Rounds

Genevoyager Investors

Notable investors and investment history

Genevoyager investors
Investor	Rounds
Hongxin Capital	Series A
SDIC Venture Capital	Series A

View all Investors

Genevoyager Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Genevoyager Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Genevoyager's valuation, stock price, and market status.

Firmographic Details

HeadquartersWuhan

Year Founded2022

Last FundingSep 12, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.